Bio & Pharma
GC Biopharma exports Alyglo to US
The S.Korean pharmaceutical company shipped the initial volume of its immunoglobulin blood product to the US
By Jul 09, 2024 (Gmt+09:00)
1
Min read
Most Read
S.Korea's LS Materials set to boost earnings ahead of IPO process
![close](/images/ico/eyes/close.png)
![open](/images/ico/eyes/open.png)
Gas maker Air Products Korea put on sale for around $3.6 bn
![close](/images/ico/eyes/close.png)
![open](/images/ico/eyes/open.png)
Carlyle, Keppel, IMM stay in final race for Ecorbit
![close](/images/ico/eyes/close.png)
![open](/images/ico/eyes/open.png)
K-content powerhouse’s YouTube channels disrupted by hacks
![close](/images/ico/eyes/close.png)
![open](/images/ico/eyes/open.png)
Mercedes, BMW, Audi, VW offer deep discounts amid EV phobia in Korea
![close](/images/ico/eyes/close.png)
![open](/images/ico/eyes/open.png)
![GC Biopharma exports Alyglo to US](https://www.kedglobal.com/data/ked/image/2024/07/09/ked202407090002.640x.0.jpg)
South Korea’s major pharmaceutical company GC Biopharma Corp. announced on Monday that it shipped the initial volume of Alygro, its immunoglobulin blood product to enter the US market.
Alyglo, which received approval from the US Food and Drug Administration (FDA) in December last year, is the primary humoral immunodeficiency (PHI) treatment.
![(Courtesy of GC Biopharma)](https://www.kedglobal.com/data/ked/image/2024/07/09/ked202407090004.620x.0.jpg)
The US is the world’s largest immunoglobin market with a value of around 16 trillion won ($11.6 billion).
The initial shipment will reach patients through specialty pharmacies across the US by mid-July.
GC Biopharma has been actively preparing for its US launch.
It secured a key partnership on July 1 with a major US Pharmacy Benefit Manager (PBM) to list Alyglo covered on their formularies (lists of approved drugs).
The company signed contracts with reputable specialty pharmacies and distributors to build a strong distribution network.
The company aims to $50 million in Alyglo sales this year and projects annual growth to capture a market share in the US.
Write to Young-Ae Lee at 0ae@hankyung.com
More to Read
-
Bio & PharmaGC Biopharma aims to boost Alyglo sales sixfold in the US
Feb 28, 2024 (Gmt+09:00)
2 Min read -
-
Bio & PharmaGC Biopharma breaks ground on blood product plant in Indonesia
Dec 06, 2023 (Gmt+09:00)
1 Min read
Comment 0
LOG IN